CompletedNot applicableNCT00480337

In Vitro Maturation of Immature Oocytes

Studying Ovarian hyperstimulation syndrome

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Sheba Medical Center
Principal Investigator: Ariel Hourvitz
IVF Unit, Sheba Medical Center
Intervention: In Vitro Maturation of immature oocytes(procedure)
Eligibility: 20-45 years · FEMALE

Study locations (1)

IVF Unit, Shea Medical Center, Tel-Hashomer, Ramat Gan, Israel

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00480337 on ClinicalTrials.gov

Other trials for Ovarian hyperstimulation syndrome

Additional recruiting or active studies for the same condition.

RECRUITINGPHASE2NCT07043322
Clinical Study to Evaluate Efficacy of Cabergoline to Coasting in Reducing the Incidence of Ovarian Hyperstimulation Syndrome
Tanta University

See all trials for Ovarian hyperstimulation syndrome →

← Back to all trials